These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8389026)
1. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial. Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026 [TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
7. [Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study]. Russell MB; Holm-Thomsen OE; Nielsen MR; Cleal A; Pilgrim AJ; Olesen J Ugeskr Laeger; 1995 Apr; 157(16):2320-3. PubMed ID: 7652970 [TBL] [Abstract][Full Text] [Related]
8. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache. Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945 [TBL] [Abstract][Full Text] [Related]
9. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Dowson AJ; Massiou H; Lainez JM; Cabarrocas X Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355 [TBL] [Abstract][Full Text] [Related]
10. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Headache; 2005; 45(7):874-82. PubMed ID: 15985104 [TBL] [Abstract][Full Text] [Related]
11. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [TBL] [Abstract][Full Text] [Related]
12. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159 [TBL] [Abstract][Full Text] [Related]
13. Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine. Barbanti P; Carpay JA; Kwong WJ; Ahmad F; Boswell D Curr Med Res Opin; 2004 Dec; 20(12):2021-9. PubMed ID: 15701219 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Diener HC Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900 [TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group. Ensink FB J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291 [TBL] [Abstract][Full Text] [Related]
17. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group. Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140 [TBL] [Abstract][Full Text] [Related]
18. Treatment of migraine attacks with sumatriptan. Subcutaneous Sumatriptan International Study Group N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495 [TBL] [Abstract][Full Text] [Related]
19. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results]. Centonze V; Polito MB; Di Bari M; Fabbri L; Cassiano MA; Bassi A; Albano O Clin Ter; 1995 Nov; 146(11):721-8. PubMed ID: 8720348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]